Voices of Healthcare · #14
Andre Esteva
Co-founder and CEO
ArteraAI
ArteraAI brought AI-personalized cancer therapy guidance into guideline and reimbursement settings that most medical AI products never reach.
Andre Esteva, PhD, is co-founder and CEO of ArteraAI, which builds AI that personalizes cancer therapy decisions. The company's work has been recognized in major clinical guideline contexts and has pursued reimbursement paths that go beyond pilot grants.
Earlier in his career he published widely cited research on deep learning for dermatology diagnosis and led medical AI work at Salesforce Research. That research-to-product path is part of why oncology AI buyers treat Artera as a reference case.
ArteraAI is not currently a scored HIR review page.